Finepoint Capital LP Eye Point Pharmaceuticals, Inc. Transaction History

Finepoint Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$5.42 - $9.22 $157,993 - $268,763	-29,150 Reduced 2.62%	1,081,954 $5.86 Million
Q4 2024 Feb 13, 2025	BUY	$7.02 - $12.12 $2.83 Million - $4.89 Million	403,700 Added 57.07%	1,111,104 $8.28 Million
Q2 2024 Aug 13, 2024	BUY	$8.16 - $22.89 $414,560 - $1.16 Million	50,804 Added 7.74%	707,404 $6.15 Million
Q1 2024 May 14, 2024	BUY	$19.93 - $29.71 $13.1 Million - $19.5 Million	656,600 New	656,600 $13.6 Million

167

68M

421K

401K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $404M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Finepoint Capital LP, based on Form 13F filings with the SEC.

Stay updated on Finepoint Capital LP with notifications on news.